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Binding brain better—matching var genes
and endothelial receptors
Hannah Fleckenstein & Silvia Portugal
Cerebral malaria remains a major cause of
death for African children, and mechanis-
tic insights regarding the establishment
of brain pathology are greatly needed.
Expression of specific domains of para-
site’s var genes promoting brain adhesion
of infected erythrocytes had been previ-
ously identified, but binding specificities
and the receptor preference in the brain
endothelial cells had not been fully
described. The study by Storm et al (2019)
in this issue of EMBO Molecular Medicine
demonstrates that binding to brain
endothelial cells via EPCR and ICAM-1 is
increased in parasites causing cerebral
malaria compared to parasites causing
uncomplicated malaria. Furthermore,
expression levels of var genes encoding
the CIDRa1 domain with EPCR affinity
correlate with the receptor-dependent
binding to brain, but not dermal endothe-
lial cells, highlighting the important role
of EPCR in cerebral malaria pathology.
EMBO Mol Med (2019) 11: e10137
See also: J Storm et al (February 2019)
D espite a substantial decrease of themalaria burden since 2010, the latestWHO analysis indicates a stalling of
the progress in recent years, in reducing
both the number of malaria cases and the
number of deaths caused by Plasmodium
falciparum. Cerebral malaria is a major
cause of P. falciparum-caused deaths, and
several mechanisms have been proposed to
be involved, including obstruction of
microvessels by sequestered infected red
blood cells (iRBCs), endothelial dysfunction,
immune activation and release of pro-
inflammatory cytokines, dysregulation of
coagulation pathways, blood–brain barrier
permeability or brain swelling. Although the
mechanisms leading to cerebral malaria are
not fully described, it appears that both
parasite and host factors contribute and that
iRBCs binding to the brain endothelial play
an important role. The study by Storm et al
links cerebral malaria-causing parasites with
a higher binding of iRBCs in the brain
endothelium through endothelial protein C
receptor (EPCR; Storm et al, 2019).
Remodelling of the host cell by P. falci-
parum and expression of parasite proteins
on the surface of iRBCs allows its sequestra-
tion to the endothelium preventing recogni-
tion and clearance by the spleen (Smith
et al, 1995). Adhesion of iRBCs is primarily
mediated by P. falciparum erythrocyte
membrane protein 1 (PfEMP1), encoded by
the var genes, of which each parasite
possesses ~ 60 mutually exclusive express-
ing genes. Binding of iRBCs can be quanti-
fied in static or flow conditions and
measured by testing parasite adhesion to
purified or recombinant versions of the
receptors, or to primary endothelial cells
from different tissues, allowing dissecting
binding specificities in the former, and a
better representation of the in vivo receptor
distribution in the latter. Binding properties
of different PfEMP1s have been linked to
single functional cysteine-rich adhesion
domains called Duffy binding-like (DBL) and
cysteine-rich interdomain region (CIDR). All
parasites carry a similar repertoire of var
genes, conferring each parasite a similar
array of possible receptor binding pheno-
types. PfEMP1s are known to bind mainly
host endothelial cell receptors EPCR or
CD36, via their CIDRa1 or CIDRa2-6
domains, respectively. This phenotype
dichotomy is maintained by a genetic orga-
nization of var genes with the subtelomeric
group A var genes encoding EPCR-binding
PfEMP1 and telomeric group B and centro-
meric group C encoding CD36-binding
PfEMP1. Most parasites also carry chimeric
group B/A var genes encoding a conserved
tandem domain arrangement (domain
cassette, DC) known as DC8, which also
binds EPCR. Some PfEMP1 of both groups A
and B bind ICAM-1 via DBLb domains
(Lavstsen et al, 2003). In addition, all para-
sites carry one gene encoding the unusual
VAR2CSA PfEMP1 binding to placental
chondroitin sulphate A and expressed by
parasites causing pregnancy malaria.
In years preceding the identification of
EPCR as a PfEMP1 receptor, transcription of
var genes encoding DC8/DC13 (groups B/A
and A, respectively) were linked with para-
sites causing cerebral malaria, and parasites
selected in vitro to bind brain endothelial
cells. Lavstsen et al introduced for the first
time a set of 42 primer pairs targeting speci-
fic CIDR and DBL subtypes and compared
var gene transcript levels in children with
uncomplicated malaria and different forms
of severe malaria. The degenerate primers
were designed to target semiconserved var
sequences specific for different domain
subclasses. With this tool and parasites from
88 children, the authors showed that vars
containing DC8 and to a lesser extent DC13
domains were consistently increased in
parasites from patients with severe malaria
compared with uncomplicated malaria
patients (Lavstsen et al, 2012). Avril et al
(2012) at the same time reported that
P. falciparum iRBCs panned on human brain
microvascular endothelial cells (HBMEC)
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altered their binding phenotype and selected
three var genes, including two that encoded
DC8 PfEMP1. Also at the same time, Claes-
sens et al analysed transcription of isogenic
pairs of parasites selected on brain endothe-
lial cells or unselected parasites with a chip
containing oligonucleotide probes for multi-
ple var genes from different P. falciparum
strains. The multiple comparisons converged
in outcome and indicated that on all selec-
tions, one or two vars showed markedly
increased transcription in the brain endothe-
lial adherent parasites and these were
consistently group A var genes (Claessens
et al, 2012). However, in none of the above-
mentioned studies the receptor affinity of
the different PfEMP1 was determined.
It was only later that EPCR was identified
by Turner et al as the molecular target of
parasites isolated from severe malaria cases
in a screening of recombinantly expressed
human endothelial receptors and binding
inhibition by receptor blockage. Subdomains
CIDRa1.1 and CIDRa1.4 were identified to
mediate EPCR binding (in DC8 and DC13
respectively), and surface plasmon reso-
nance experiments showed that the binding
occurred at significantly higher strengths as
EPCRs binding to its natural ligand activated
protein C (Turner et al, 2013). In a later
study, Lau et al (2015) found, using struc-
tural analyses, that all but two CIDRa1
subtypes (CIDRa1.2 and CIDRa1.3 found in
the var1 pseudogenes) bind to EPCR.
More recently parasites causing cerebral
malaria were shown to express var genes
encoding for PfEMP1s that bind EPCR and
ICAM-1 in static binding assays (Tuikue
Ndam et al, 2017). Parasites from children
with cerebral or uncomplicated malaria were
characterized in their transcribed var gene
and the binding properties of iRBC collected
on admission. High expression levels of
PfEMP1 predicted to bind EPCR were signifi-
cantly more frequent among parasites of
patients with cerebral malaria than among
uncomplicated malaria cases. And, when the
binding capacity to CD36, ICAM-1 or EPCR
was investigated, adhesion to EPCR and
ICAM-1 was more common in cerebral
malaria-causing parasites than in uncompli-
cated malaria-causing parasites. Further-
more, parasite isolates from cerebral malaria
patients more frequently exhibited binding
to both ICAM-1 and EPCR, whereas binding
to CD36 was more frequent in uncompli-
cated malaria than cerebral malaria patients
(Tuikue Ndam et al, 2017).
However, in this study a direct link
between var genes encoding for PfEMP1
binding to EPCR and adhesion to brain cells
of cerebral malaria-causing parasites contin-
ued to be elusive.
In this issue of EMBO Molecular Medi-
cine, Storm et al (2019) now used a micro-
channel flow adhesion assay to enquire how
inhibition of iRBC cytoadhesion through
blocking ICAM-1, CD36 or EPCR on brain or
dermal endothelial cells affects binding of
parasites causing cerebral malaria or uncom-
plicated malaria. Parasites collected from
children with cerebral malaria or uncompli-
cated malaria were allowed to bind to
HBMEC or human dermal microvascular
endothelial cells (HDMEC) in flow condi-
tions. The data show that cerebral malaria-
causing parasites bind better to HBMEC than
uncomplicated malaria-causing parasites; no
such difference is observed when either type
of parasite is overlaid on HDMECs. Interest-
ingly, cerebral malaria-causing parasites
bind equally well to HBMEC and HDMEC,
but uncomplicated malaria-causing parasites
adhere better to HDMEC than to HBMEC at
least through ICAM-1 binding (Fig 1). These
observations are in line with earlier autopsy
studies showing that CM patients have wide-
spread parasite sequestration in most other
organs apart from the brain.
Storm et al also investigated how the
blocking of different endothelial receptors
would affect binding of cerebral malaria- or
uncomplicated malaria-causing parasites.
ICAM-1 was blocked with antibodies in both
HBMEC and HDMEC, while CD36 was
blocked in HDMEC, and in all conditions,
antibodies could block ~ 50% of adhesion
independently of the parasites originating
from cerebral malaria or uncomplicated
malaria cases. EPCR binding of iRBCs from
cerebral malaria or uncomplicated malaria
cases was reduced in HBMEC after blocking
the receptor with a recombinant protein
version (rEPCR), but in the dermal endothe-
lial cells this effect was only visible for para-
sites originating from cerebral malaria cases.
When assessing the inhibition ability of
rEPCR on the different cell types and para-
sites origins, the authors found a trend
towards a higher inhibition of binding of
cerebral malaria-causing parasites than
uncomplicated malaria-causing parasites to
HBMEC, and this difference did not reach
statistical significance.
In parallel, the authors characterized the
var gene transcripts in each of the field
isolates used in the above-mentioned adhe-
sion assay. Performing qPCR with a recently
improved set of var typing primer pairs
targeting specific CIDR and DBL subtypes
normalized to a housekeeping gene, the
authors calculated the relative level of var
transcripts to the level of the housekeeping
gene transcript in each sample. Interestingly,
when var transcript levels were correlated
with iRBCs binding capacities to HBMEC or
HDMEC, it showed a strong positive correla-
tion between % binding attributed to EPCR
binding and expression of EPCR-binding var
domains by parasites from cerebral malaria
patients, supporting that cerebral malaria is
indeed promoted by EPCR binding of para-
sites to the brain endothelium.
Adding on to previous reports, Storm
et al attempted to recapitulate in the small
in vitro flow chambers how parasites
expressing different var genes lead to dif-
ferent clinical outcomes by comparing their
binding abilities to brain or dermal endothe-
lial cells through CD36, ICAM-1 and EPCR.
Importantly, Storm et al use in their assays
iRBCs in the 1st–3rd cycle after blood collec-
tion expressing the native full-length
PfEMP1s, and endothelial cell lines naturally
expressing their receptors, avoiding possible
affinity artefacts introduced by analyses of
individual recombinant PfEMP1 domains on
plates coated with recombinant protein
(Azasi et al, 2018). The data obtained are
indeed supportive of EPCR being an impor-
tant endothelial receptor responsible for
iRBCs binding in cerebral malaria cases,
alongside ICAM-1 (Storm et al, 2019).
None of the main endothelial receptors to
which PfEMP1s bind is selectively expressed
on the brain endothelium. Thus, it is most
likely that cerebral malaria-causing parasites
do not adhere specifically to the brain, but
rather bind to all EPCR and ICAM-1 express-
ing tissues, or even additional other recep-
tors, such as gC1qR, which has been
associated with severe malaria and rosetting,
but remains to be investigated in the context
of cerebral malaria (Mayor et al, 2011).
EPCR binding in the brain endothelium by
PfEMP1 subdomains may also increase brain
pathology by contributing to inflammation
and brain swelling. The competitive effect of
PfEMP1 subdomains decreases protein C
activation, possibly resulting in increased
blood coagulation, inflammation, recruit-
ment of immune cells to the endothelium
and obstruction of the endothelial barrier
(Turner et al, 2013).
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And why does cerebral malaria occur
only in a small proportion of the cases?
Possibly because EPCR-binding PfEMP1 is
highly immunogenic and induces antibodies
that cross-react with different EPCR-binding
PfEMP1 variants (Lau et al, 2015). Thus,
young children surviving these infections
develop antibodies against EPCR-binding
subdomains early in life, in particular if they
live in a high-transmission environment as
shown by Turner et al (2015).
Incremental knowledge of the mecha-
nisms leading to cerebral malaria associated
pathology will inform the development of
much-needed adjunctive therapies which
might prevent the too many children’s
deaths that malaria imposes annually.
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Figure 1. Binding properties of different Plasmodium falciparum clinical isolates to brain and dermal human endothelial cells.
Plasmodium falciparum clinical isolates from patients with uncomplicated (UM) or cerebral malaria (CM) were assessed for binding to human brain microvascular
endothelial cells (HBMEC) or human dermal microvascular endothelial cells (HDMEC) in a flow assay, and associated receptors usage was analysed through receptor
blocking. This simplified graph shows that higher binding to brain endothelial cells by CM- compared to UM causing parasites correlated with a higher expression of EPCR
binding domains, e.g. subtypes of the CIDRɑ1 domain.
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